Your browser doesn't support javascript.
Interleukin-6 level is an independent predictor of right ventricular systolic dysfunction in patients hospitalized with COVID-19.
Erdogan, Mehmet; Kaya Kalem, Ayse; Öztürk, Selçuk; Erdöl, Mehmet Akif; Kayaaslan, Bircan; Özbebek, Yunus Emre; Güner, Rahmet.
  • Erdogan M; Department of Cardiology, Ankara Yildirim Beyazit University, Faculty of Medicine, Turkey.
  • Kaya Kalem A; Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Faculty of Medicine, Turkey.
  • Öztürk S; Department of Cardiology, Yozgat Bozok University, Faculty of Medicine, Turkey.
  • Erdöl MA; Department of Cardiology, Ministry of Health, Ankara Bilkent City Hospital, Turkey.
  • Kayaaslan B; Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Faculty of Medicine, Turkey.
  • Özbebek YE; Department of Cardiology, Ankara Yildirim Beyazit University, Faculty of Medicine, Turkey.
  • Güner R; Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Faculty of Medicine, Turkey.
Anatol J Cardiol ; 25(8): 555-564, 2021 08.
Article in English | MEDLINE | ID: covidwho-1341860
ABSTRACT

OBJECTIVE:

Cytokine storm with elevated levels of multiple proinflammatory cytokines and inflammatory system activation underlie the pathogenesis of coronavirus disease 2019 (COVID-19). In this study, we aimed to investigate whether increased interleukin (IL)-6 levels can predict right ventricular (RV) systolic impairment in patients hospitalized with COVID-19.

METHODS:

This prospective, observational study included 100 consecutive patients hospitalized with mild and moderate COVID-19. All the patients underwent chest computerized tomography, detailed laboratory tests including IL-6, and two dimensional (2D) transthoracic echocardiography (TTE) with assessment of 2D conventional and Doppler echocardiography parameters and RV systolic functions.

RESULTS:

After the elimination of six patients with exclusion criteria, the remaining patients were classified into two groups, namely normal RV systolic functions (n=60) and impaired RV systolic functions (n=34). IL-6 levels were significantly higher in patients with impaired RV systolic functions than in those with normal RV systolic functions (20.3, 4.6, p<0.001, respectively). Tricuspid annular plane systolic excursion and RV derived tissue Doppler imaging (TDI) S' measurements were similar between the two groups. RV fractional area change was significantly lower, and RV TDI derived index of myocardial performance was significantly higher in patients with impaired RV systolic functions. In multivariate analysis, IL-6 levels independently predicted deterioration in RV systolic function at a significant level (odds ratio 1.12, 95% confidence interval 1.04-1.20, p=0.003).

CONCLUSION:

IL-6 is an independent predictor of RV systolic impairment in patients hospitalized with mild and moderate COVID-19 suggesting a possible pathogenetic mechanism. IL-6 levels can be used to predict RV systolic impairment in patients suffering from this infection.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interleukin-6 / Ventricular Dysfunction, Right / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: Anatol J Cardiol Year: 2021 Document Type: Article Affiliation country: AnatolJCardiol.2021.24946

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Interleukin-6 / Ventricular Dysfunction, Right / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: Anatol J Cardiol Year: 2021 Document Type: Article Affiliation country: AnatolJCardiol.2021.24946